Ahmed Hamdy
Chief Executive Officer at VINCERX PHARMA, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
Dr. Ahmed M.
Hamdy, MD, is a Member-Deans Council at Baskin School of Engineering, a Chairman & Chief Executive Officer at Vincerx Pharma, Inc., a Director & Clinical Advisor at Andes Biotechnologies Global, Inc., an Independent Director at Andes Biotechnologies SA and a Member-Presidents Council at The Palo Alto Medical Foundation.
He is on the Board of Directors at Andes Biotechnologies Global, Inc. and Andes Biotechnologies SA. Dr. Hamdy was previously employed as a Member by AstraZeneca PLC, a Chief Medical Officer by Pharmacyclics, Inc., a Medical Director by ALZA Corp., a Medical Director by Johnson & Johnson, a Senior Principal Scientist by Watson Pharmaceuticals, Inc., a Co-Founder by Acerta Pharma BV, and a Co-Founder by Acerta Pharma LLC.
He received his undergraduate degree from KasrAlAiny School of Medicine and a doctorate degree from the University of Cairo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VINCERX PHARMA INC
6.25% | 2024-05-22 | 1,714,259 ( 6.25% ) | 2 M $ | 2024-04-29 |
Ahmed Hamdy active positions
| Companies | Position | Start |
|---|---|---|
| VINCERX PHARMA, INC. | Chief Executive Officer | 2019-02-28 |
Andes Biotechnologies Global, Inc.
 Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA. | Director/Board Member | 2016-08-31 |
| Baskin School of Engineering | Corporate Officer/Principal | 2019-03-31 |
| The Palo Alto Medical Foundation | Corporate Officer/Principal | 2016-02-29 |
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Director/Board Member | 2016-08-31 |
Former positions of Ahmed Hamdy
| Companies | Position | End |
|---|---|---|
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 2011-06-22 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 2006-01-31 |
| ALZA CORPORATION | Chief Tech/Sci/R&D Officer | 2006-01-31 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 2004-07-31 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░ | - |
Training of Ahmed Hamdy
| University of Cairo | Doctorate Degree |
| KasrAlAiny School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Private companies | 9 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| Vincerx Pharma, Inc. | |
| Acerta Pharma LLC | |
Andes Biotechnologies Global, Inc.
Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA. | Health Technology |
| The Palo Alto Medical Foundation | Health Services |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Health Technology |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
- Stock Market
- Insiders
- Ahmed Hamdy
